Oracle Corporation (ORCL)

ORCL (NYSE:Computer Software & Services)
$40.39
neg -0.57
-1.39%
Today's Range: 40.35 - 40.94 | ORCL Avg Daily Volume: 13,703,800
Last Update: 07/31/14 - 4:04 PM EDT
Volume: 13,635,446
YTD Performance: 7.06%
Open: $40.52
Previous Close: $40.96
52 Week Range: $31.56 - $43.19
Oustanding Shares: 4,454,889,000
Market Cap: 181,002,140,070
6-Month Chart
TheStreet Ratings Grade for ORCL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 15 14 13
Moderate Buy 1 1 2 2
Hold 7 7 8 9
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.78 1.75 1.82 1.90
Latest Dividend: 0.12
Latest Dividend Yield: 1.18%
Dividend Ex-Date: 07/07/14
Price Earnings Ratio: 17.07
Price Earnings Comparisons:
ORCL Sector Avg. S&P 500
17.07 17.10 28.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.20% 25.84% 33.94%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.90 0.07 0.02
Net Income 0.30 0.28 0.09
EPS 5.50 0.43 0.13
Earnings for ORCL:
EBITDA 17.89B
Revenue 38.28B
Average Earnings Estimates
Qtr (08/14) Qtr (11/14) FY (05/15) FY (05/16)
Average Estimate $0.60 $0.70 $3.01 $3.28
Number of Analysts 8 8 9 9
High Estimate $0.61 $0.72 $3.11 $3.44
Low Estimate $0.59 $0.69 $2.94 $3.14
Prior Year $0.56 $0.66 $2.73 $3.01
Growth Rate (Year over Year) 7.81% 6.06% 10.38% 8.70%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 25, 2014 | 7:14 PM EDT

These stocks seem to be plateauing.

By

Gary Morrow

 | Jul 17, 2014 | 3:51 PM EDT

The stock is on the brink of an ugly breakdown.

updateORCL Analyst Mtg.

Jul 16, 2014 | 6:29 AM EDT

ORCL - Oracle Corp Corporate Analyst Meeting - Emerging Trends in Database - 12:15PM 

By

Jim Cramer

 | Jul 8, 2014 | 4:08 PM EDT

The lower risk stocks have been providing consistent returns.

By

Chris Laudani

 | Jul 3, 2014 | 8:30 AM EDT

Concur looks like a buy if you can get past its high valuation.

By

Doug Kass

 | Jun 27, 2014 | 11:31 AM EDT
Speculative and disruptive companies often face skepticism and share price corrections in their early growth phase.
By

Doug Kass

 | Jun 25, 2014 | 2:04 PM EDT
Yesterday's Oracle cover.
By

Doug Kass

 | Jun 24, 2014 | 12:07 PM EDT
And the prices at which they were made.
By

Doug Kass

 | Jun 24, 2014 | 11:10 AM EDT
Namely, RTH and Oracle.
By

Doug Kass

 | Jun 24, 2014 | 7:50 AM EDT
Here's the rundown.
Volume in the SPY today was nearly double its 50 day average of volume. (The graph at the ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Market got beat like a rented mule today as equities posted their second worst day of the ...

down 302 now, at 16577 the dow 30 is unchanged for 2014. roll the media hype!

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.